← Every applicant
Tris Pharma Inc FDA Approvals
9 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| GANIRELIX ACETATENew drugJun 27, 2025INJECTABLE, INJECTION |
| ONYDA XRNew drugMay 24, 2024SUSPENSION, EXTENDED RELEASE, ORAL |
| DEFLAZACORTNew drugApr 25, 2024SUSPENSION, ORAL |
| DEXTROAMPHETAMINE SULFATENew drugAug 18, 2022TABLET, ORAL |
| POTASSIUM CHLORIDENew drugJan 26, 2022SOLUTION, ORAL |
| HYDROCODONE BITARTRATE AND ACETAMINOPHENNew drugDec 30, 2021SOLUTION, ORAL |
| CYPROHEPTADINE HYDROCHLORIDENew drugDec 21, 2021SYRUP, ORAL |
| SILDENAFIL CITRATENew drugNov 17, 2021FOR SUSPENSION, ORAL |
| DYANAVEL XR 20New drugNov 4, 2021TABLET, EXTENDED RELEASE, ORAL |